COMPANY

Company history

“ Korean Drug Co. Ltd is a company that challenges the future with unprecedented growth and development

2010 ~ 2019

  • 2019

    • Nov.Designation as a company applying good manufacturing practice (GMP) for health functional food.

  • 2016

    • Jul.National research funding of KRW 550 million for development of new functional food ingredients in the use of Portulaca extracts.

  • 2015

    • Nov.Investment of 5% in share of "DIAMESCO Co, Ltd.', digital insulin pen development company.

    • Sept.National research funding of KRW 1.2 billion for atopic dermatitis research.

  • 2014

    • Jul.Selection of the Agricultural biotechnology development business with utilizing common sage for osteoporosis treatment business, national research funding of KRW 5 billion